FDA advisory panel endorses booster doses of Johnson & Johnson’s single-shot COVID-19 vaccine

FILE - This Dec. 2, 2020, file photo provided by Johnson & Johnson shows vials of the COVID-19 vaccine in the United States. (Johnson & Johnson via AP)
FILE - This Dec. 2, 2020, file photo provided by Johnson & Johnson shows vials of the COVID-19 vaccine in the United States. (Johnson & Johnson via AP)

The FDA isn’t bound by the vote but its ultimate decision could help expand the nation’s booster campaign.

Posted: Oct 15, 2021 12:40 PM
Updated: Oct 15, 2021 12:41 PM

WASHINGTON (AP) - A panel of U.S. health advisers has endorsed booster doses of Johnson & Johnson’s single-shot COVID-19 vaccine.

The Food and Drug Administration panel said Friday that the booster should be offered at least two months after immunization but didn't suggest a firm time.

The FDA isn’t bound by the vote but its ultimate decision could help expand the nation’s booster campaign.

Booster doses of Pfizer’s vaccine began last month for people at high risk of COVID-19, and the FDA advisory panel has recommended the same approach for Moderna.

Huntsville
Clear
32° wxIcon
Hi: 64° Lo: 31°
Feels Like: 32°
Florence
Partly Cloudy
34° wxIcon
Hi: 66° Lo: 29°
Feels Like: 34°
Fayetteville
Partly Cloudy
32° wxIcon
Hi: 63° Lo: 30°
Feels Like: 27°
Decatur
Clear
29° wxIcon
Hi: 65° Lo: 32°
Feels Like: 29°
Scottsboro
Partly Cloudy
26° wxIcon
Hi: 62° Lo: 32°
Feels Like: 26°
WAAY Radar
WAAY WAAY-TV Cam
WAAY Temperatures

 

Community Events